Postmarketing Safety Studies
Use Qdata, quality real-world data (RWD), to help satisfy regulatory requirements for postmarketing safety data. Qdata is derived from exclusive, speciality electronic health care records (EHRs), so we can help you better identify adverse events that may be difficult to assess in prospective research. We can help you track early usage of your drug or device in the market while monitoring safety events to help meet FDA or other regulatory commitments.
Treatment Patterns and Outcomes
Activate our exclusive Qdata to deeply understand treatment patterns and outcomes of your therapeutic in the real world. Qdata leverages both structured and unstructured EHR data—including physician notes—to provide a deep understanding of symptoms, diagnoses, reasons for treatment changes, side effects, and patient outcomes over time. We can help you track how your therapy is performing within select de-identified patient cohorts to inform business decisions.
Pricing and Market Access Study
Leverage comprehensive Qdata to understand where your patients are accessing therapies and how that compares to others in the market. We can help uncover and monitor where and how your therapy is being adopted in the real-world to inform your market access and commercial strategies.
Patient Journey and Patient Burden
Uncover the patient journey and burden-of-disease by leveraging longitudinal Qdata. Qdata stems from real-world data generated from more than 20,000 healthcare providers and 70 EHRs across Verana’s three registries —and is often linked with claims data to inform real-world evidence (RWE). You can gain quality insights from the breadth and depth of our exclusive datasets in ophthalmology, neurology, and urology—from initial symptoms and diagnosis to treatment switching and long-term patient outcomes.
Comparative Effectiveness
Leverage Verana Health’s exclusive Qdata to answer your comparative effectiveness research questions. Analysis of Qdata can help deliver insight into which therapies work best for which patients and where the greatest benefits or potential issues may lie across patient cohorts in the real world. We can help you understand how use of your therapy in the market is measuring against other interventions to inform business strategy and decisions.
